In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups

This publication has 25 references indexed in Scilit:

• Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 2000
• Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia
  Leukemia & Lymphoma, 2000
• Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies
  Cancer, 1998
• Mechanisms of cellular anthracycline resistance in childhood acute leukemia.
  Leukemia, 1998
• In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia
  Blood, 1997
• Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts
  Leukemia, 1997
• The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]
  Blood, 1996
• BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]
  Blood, 1994
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.
  Molecular and Cellular Biology, 1985